In contrast to this, 72% the 2000 hypermethylated sites in AML were also positively associated with TET2 mutations in CCUS granulocytes (P < 1 × 10−16, χ2 test, Fig. 5c). The gene discussed is TET2; the disease is acute myeloid leukemia.